封面
市場調查報告書
商品編碼
1356827

轉染技術市場報告:至2030年的趨勢、預測與競爭分析

Tranfection Technology Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

轉染技術趨勢與預測

到2030年,全球轉染技術市場預計將達到 27 億美元,2024年至2030年年複合成長率為 7.1%。市場的主要促進因素是慢性病盛行率的增加和細胞療法投資的增加。全球轉染技術市場前景廣闊,治療藥物傳遞、醫學研究和蛋白質生產市場都有機會。

轉染技術市場洞察

Lucintel 預測,基於試劑的方法將在預測期內實現高速成長。

預計生物醫學研究將在預測期內實現最高成長。

由於感染疾病的流行,細胞產品的使用增加以及主要企業的存在,預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題:

  • Q.1.細分市場中最有前途和高成長的機會為何?
  • Q.2.哪個細分市場將以更快的速度成長?理由為何?
  • Q.3.哪些地區未來會出現更快的成長?理由為何?
  • Q.4.影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5.這個市場的商業風險和競爭威脅為何?
  • Q.6.這個市場有哪些新趨勢?理由為何?
  • Q.7.市場客戶需求有何改變?
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10.該市場上的競爭產品有哪些,由於材料或產品替代導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球轉染技術市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球轉染技術市場趨勢(2018-2023)與預測(2024-2030)
  • 按方法分類的全球轉染技術市場
    • 基於試劑的方法
    • 基於儀器的方法
    • 其他
  • 依技術分類的全球轉染技術市場
    • 物理轉染
    • 基於生物化學的轉染
    • 基於病毒載體的轉染
  • 全球轉染技術市場(依應用)
    • 治療實施
    • 生物醫學研究
    • 蛋白質生產
  • 以最終用途分類的全球轉染技術市場
    • 研究中心和學術機構
    • 醫院和診所
    • 製藥和生物技術公司
    • 其他

第4章 2018-2030年市場趨勢及預測分析(依地區)

  • 全球轉染技術市場區域分佈
  • 北美轉染技術市場
  • 歐洲轉染技術市場
  • 亞太轉染技術市場
  • 其他區域轉染技術市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球轉染技術市場成長機會(依方法)
    • 全球轉染技術市場成長機會(依技術)
    • 全球轉染技術市場成長機會(依應用)
    • 全球轉染技術市場成長機會(依最終用途)
    • 全球轉染技術市場成長機會(依地區)
  • 全球轉染技術市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球轉染技術市場的產能
    • 全球轉染技術市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte
簡介目錄

Tranfection Technology Trends and Forecast

The future of the global tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets. The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

A more than 150-page report is developed to help in your business decisions.

Tranfection Technology by Segment

The study includes a forecast for the global tranfection technology by method, technology, application, end use, and region.

Tranfection Technology Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Reagent-Based Method
  • Instrument-Based Method
  • Others

Tranfection Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Tranfection Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production

Tranfection Technology Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Tranfection Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Tranfection Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tranfection technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tranfection technology companies profiled in this report include-

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte

Tranfection Technology Market Insights

Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Bio-medical research is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Features of the Global Tranfection Technology Market

Market Size Estimates: Tranfection technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Tranfection technology market by various segments, such as by method, technology, application, end use, and region. in terms of($B).

Regional Analysis: Tranfection technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, technologies, applications, end uses, and region.s for the tranfection technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tranfection technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the tranfection technology market size?

Answer: The global tranfection technology market is expected to reach an estimated $2.7 billion by 2030.

Q.2. What is the growth forecast for tranfection technology market?

Answer: The global tranfection technology market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the tranfection technology market?

Answer: The major drivers for this market are growing prevalence of chronic diseases and rising investment in cell-based therapies.

Q.4. What are the major segments for tranfection technology market?

Answer: The future of the tranfection technology market looks promising with opportunities in the therapeutic delivery, bio-medical research, and protein production markets.

Q.5. Who are the key tranfection technology market companies?

Answer: Some of the key tranfection technology companies are as follows:

  • Life Technologies
  • Sigma Aldrich
  • Lonza
  • Promega
  • Qiagen
  • Bio-Rad
  • Roche
  • Polyplus Transfection
  • Mirius Bio
  • Maxcyte

Q.6. Which tranfection technology market segment will be the largest in future?

Answer: Lucintel forecasts that reagent-based method is expected to witness higher growth over the forecast period.

Q.7. In tranfection technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising prevalence of infectious diseases, growing use of cell-based products, and presence of key players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the tranfection technology market by method (reagent-based method, instrument-based method, and others), technology (physical transfection, biochemical based transfection, and viral-vector based transfection), application (therapeutic delivery, bio-medical research, and protein production), end use (research centers and academic institutes, hospitals and clinics, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tranfection Technology Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Tranfection Technology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Tranfection Technology Market by Method
    • 3.3.1: Reagent-Based Method
    • 3.3.2: Instrument-Based Method
    • 3.3.3: Others
  • 3.4: Global Tranfection Technology Market by Technology
    • 3.4.1: Physical Transfection
    • 3.4.2: Biochemical Based Transfection
    • 3.4.3: Viral-Vector Based Transfection
  • 3.5: Global Tranfection Technology Market by Application
    • 3.5.1: Therapeutic Delivery
    • 3.5.2: Bio-Medical Research
    • 3.5.3: Protein Production
  • 3.6: Global Tranfection Technology Market by End Use
    • 3.6.1: Research Centers and Academic Institutes
    • 3.6.2: Hospitals and Clinics
    • 3.6.3: Pharmaceutical and Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Tranfection Technology Market by Region
  • 4.2: North American Tranfection Technology Market
    • 4.2.2: North American Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.3: European Tranfection Technology Market
    • 4.3.1: European Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.3.2: European Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.4: APAC Tranfection Technology Market
    • 4.4.1: APAC Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.4.2: APAC Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production
  • 4.5: ROW Tranfection Technology Market
    • 4.5.1: ROW Tranfection Technology Market by Method: Reagent-Based Method, Instrument-Based Method, and Others
    • 4.5.2: ROW Tranfection Technology Market by Application: Therapeutic Delivery, Bio-Medical Research, and Protein Production

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Tranfection Technology Market by Method
    • 6.1.2: Growth Opportunities for the Global Tranfection Technology Market by Technology
    • 6.1.3: Growth Opportunities for the Global Tranfection Technology Market by Application
    • 6.1.4: Growth Opportunities for the Global Tranfection Technology Market by End Use
    • 6.1.5: Growth Opportunities for the Global Tranfection Technology Market by Region
  • 6.2: Emerging Trends in the Global Tranfection Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Tranfection Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tranfection Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Life Technologies
  • 7.2: Sigma Aldrich
  • 7.3: Lonza
  • 7.4: Promega
  • 7.5: Qiagen
  • 7.6: Bio-Rad
  • 7.7: Roche
  • 7.8: Polyplus Transfection
  • 7.9: Mirius Bio
  • 7.10: Maxcyte